Motasem Melhem1, Mohamed Abu-Farha2, Dinu Antony1, Ashraf Al Madhoun1, Chiara Bacchelli3, Fadi Alkayal4, Irina AlKhairi2, Sumi John5, Mohamad Alomari6, Phillip L Beales3, Osama Alsmadi1. 1. Genetics and Genomics Department, Dasman Diabetes Institute, Dasman, Kuwait. 2. Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Dasman, Kuwait. 3. Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK. 4. Pancreatic Islet Biology & Transplantation Unit, Dasman Diabetes Institute, Dasman, Kuwait. 5. Integrative Informatics, Dasman Diabetes Institute, Dasman, Kuwait. 6. Department of Pathology, Windsor Regional Hospital, Windsor, ON, Canada.
Abstract
OBJECTIVE: To characterize the underlying genetic and molecular defects in a consanguineous family with lifelong blood disorder manifested with thrombocytopenia (low platelets count) and anemia. METHODS: Genetic linkage analysis, exome sequencing, and functional genomics were carried out to identify and characterize the defective gene. RESULTS: We identified a novel truncation mutation (p.C108*) in chromosome 6 open reading frame 25 (C6orf25) gene in this family. We also showed the p.C108* mutation was responsible for destabilizing the encoded truncated G6B protein. Unlike the truncated form, wild-type G6B expression resulted in enhanced K562 differentiation into megakaryocytes and erythrocytes. C6orf25, also known as G6B, is an effector protein for the key hematopoiesis regulators, Src homology region 2 domain-containing phosphatases SHP-1 and SHP-2. CONCLUSION: G6B seems to act through an autosomal recessive mode of disease transmission in this family and regarded as the gene responsible for the observed hematological disorder. This inference is well supported further by in vivo evidence where similar outcomes were reported from G6b-/- and SHP1/2 DKO mouse models.
OBJECTIVE: To characterize the underlying genetic and molecular defects in a consanguineous family with lifelong blood disorder manifested with thrombocytopenia (low platelets count) and anemia. METHODS: Genetic linkage analysis, exome sequencing, and functional genomics were carried out to identify and characterize the defective gene. RESULTS: We identified a novel truncation mutation (p.C108*) in chromosome 6 open reading frame 25 (C6orf25) gene in this family. We also showed the p.C108* mutation was responsible for destabilizing the encoded truncated G6B protein. Unlike the truncated form, wild-type G6B expression resulted in enhanced K562 differentiation into megakaryocytes and erythrocytes. C6orf25, also known as G6B, is an effector protein for the key hematopoiesis regulators, Src homology region 2 domain-containing phosphatases SHP-1 and SHP-2. CONCLUSION: G6B seems to act through an autosomal recessive mode of disease transmission in this family and regarded as the gene responsible for the observed hematological disorder. This inference is well supported further by in vivo evidence where similar outcomes were reported from G6b-/- and SHP1/2 DKO mouse models.
Authors: Sophie Cardin; Mélanie Bilodeau; Mathieu Roussy; Léo Aubert; Thomas Milan; Loubna Jouan; Alexandre Rouette; Louise Laramée; Patrick Gendron; Jean Duchaine; Hélène Decaluwe; Jean-François Spinella; Stéphanie Mourad; Françoise Couture; Daniel Sinnett; Élie Haddad; Josette-Renée Landry; Jing Ma; R Keith Humphries; Philippe P Roux; Josée Hébert; Tanja A Gruber; Brian T Wilhelm; Sonia Cellot Journal: Blood Adv Date: 2019-11-12
Authors: Timo Vögtle; Sumana Sharma; Jun Mori; Zoltan Nagy; Daniela Semeniak; Cyril Scandola; Mitchell J Geer; Christopher W Smith; Jordan Lane; Scott Pollack; Riitta Lassila; Annukka Jouppila; Alastair J Barr; Derek J Ogg; Tina D Howard; Helen J McMiken; Juli Warwicker; Catherine Geh; Rachel Rowlinson; W Mark Abbott; Anita Eckly; Harald Schulze; Gavin J Wright; Alexandra Mazharian; Klaus Fütterer; Sundaresan Rajesh; Michael R Douglas; Yotis A Senis Journal: Elife Date: 2019-08-22 Impact factor: 8.140
Authors: Inga Hofmann; Mitchell J Geer; Timo Vögtle; Andrew Crispin; Dean R Campagna; Alastair Barr; Monica L Calicchio; Silke Heising; Johanna P van Geffen; Marijke J E Kuijpers; Johan W M Heemskerk; Johannes A Eble; Klaus Schmitz-Abe; Esther A Obeng; Michael Douglas; Kathleen Freson; Corinne Pondarré; Rémi Favier; Gavin E Jarvis; Kyriacos Markianos; Ernest Turro; Willem H Ouwehand; Alexandra Mazharian; Mark D Fleming; Yotis A Senis Journal: Blood Date: 2018-06-13 Impact factor: 22.113
Authors: Isabelle C Becker; Zoltan Nagy; Georgi Manukjan; Melanie Haffner-Luntzer; Maximilian Englert; Tobias Heib; Timo Vögtle; Carina Gross; Richa Bharti; Sascha Dietrich; Kristina Mott; Johannes Heck; Sebastian Stegmaier; Anke Baranowsky; Thorsten Schinke; Nicolas Schlegel; Tobias Heckel; David Stegner; Irina Pleines; Anita Ignatius; Harald Schulze; Bernhard Nieswandt Journal: Blood Adv Date: 2022-05-24
Authors: Mitchell J Geer; Johanna P van Geffen; Piraveen Gopalasingam; Timo Vögtle; Christopher W Smith; Silke Heising; Marijke J E Kuijpers; Bibian M E Tullemans; Gavin E Jarvis; Johannes A Eble; Mark Jeeves; Michael Overduin; Johan W M Heemskerk; Alexandra Mazharian; Yotis A Senis Journal: Blood Date: 2018-06-11 Impact factor: 22.113